Engineering chromosome rearrangements in cancer

The identification of large chromosomal rearrangements in cancers has multiplied exponentially over the last decade. These complex and often rare genomic events have traditionally been challenging to study, in part owing to lack of tools that efficiently engineer disease-associated inversions, delet...

Full description

Bibliographic Details
Main Authors: Salvador Alonso, Lukas E. Dow
Format: Article
Language:English
Published: The Company of Biologists 2021-09-01
Series:Disease Models & Mechanisms
Subjects:
Online Access:http://dmm.biologists.org/content/14/9/dmm049078
_version_ 1818575429088313344
author Salvador Alonso
Lukas E. Dow
author_facet Salvador Alonso
Lukas E. Dow
author_sort Salvador Alonso
collection DOAJ
description The identification of large chromosomal rearrangements in cancers has multiplied exponentially over the last decade. These complex and often rare genomic events have traditionally been challenging to study, in part owing to lack of tools that efficiently engineer disease-associated inversions, deletions and translocations in model systems. The emergence and refinement of genome editing technologies, such as CRISPR, have significantly expanded our ability to generate and interrogate chromosomal aberrations to better understand the networks that govern cancer growth. Here we review how existing technologies are employed to faithfully model cancer-associated chromosome rearrangements in the laboratory, with the ultimate goal of developing more accurate pre-clinical models of and therapeutic strategies for cancers driven by these genomic events.
first_indexed 2024-12-15T00:40:10Z
format Article
id doaj.art-eda448234cfe4f4da8c0d419f9cf9553
institution Directory Open Access Journal
issn 1754-8403
1754-8411
language English
last_indexed 2024-12-15T00:40:10Z
publishDate 2021-09-01
publisher The Company of Biologists
record_format Article
series Disease Models & Mechanisms
spelling doaj.art-eda448234cfe4f4da8c0d419f9cf95532022-12-21T22:41:41ZengThe Company of BiologistsDisease Models & Mechanisms1754-84031754-84112021-09-0114910.1242/dmm.049078049078Engineering chromosome rearrangements in cancerSalvador Alonso0Lukas E. Dow1 Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, NY 10021, USA Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, NY 10021, USA The identification of large chromosomal rearrangements in cancers has multiplied exponentially over the last decade. These complex and often rare genomic events have traditionally been challenging to study, in part owing to lack of tools that efficiently engineer disease-associated inversions, deletions and translocations in model systems. The emergence and refinement of genome editing technologies, such as CRISPR, have significantly expanded our ability to generate and interrogate chromosomal aberrations to better understand the networks that govern cancer growth. Here we review how existing technologies are employed to faithfully model cancer-associated chromosome rearrangements in the laboratory, with the ultimate goal of developing more accurate pre-clinical models of and therapeutic strategies for cancers driven by these genomic events.http://dmm.biologists.org/content/14/9/dmm049078crisprcancerchromosomal rearrangementsfusion oncogenes
spellingShingle Salvador Alonso
Lukas E. Dow
Engineering chromosome rearrangements in cancer
Disease Models & Mechanisms
crispr
cancer
chromosomal rearrangements
fusion oncogenes
title Engineering chromosome rearrangements in cancer
title_full Engineering chromosome rearrangements in cancer
title_fullStr Engineering chromosome rearrangements in cancer
title_full_unstemmed Engineering chromosome rearrangements in cancer
title_short Engineering chromosome rearrangements in cancer
title_sort engineering chromosome rearrangements in cancer
topic crispr
cancer
chromosomal rearrangements
fusion oncogenes
url http://dmm.biologists.org/content/14/9/dmm049078
work_keys_str_mv AT salvadoralonso engineeringchromosomerearrangementsincancer
AT lukasedow engineeringchromosomerearrangementsincancer